# DEFERASIROX
> **ANDA207124** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2022-09-23
## Drug
- **FDA Application Number:** ANDA207124
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEFERASIROX
- **Generic name:** DEFERASIROX
- **Active ingredients:** DEFERASIROX
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2022-09-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207124)
---
*AI Analytics · CC0 1.0*